Peptides

Copper Peptides for Hair Loss: Legit Treatment or TikTok Hype?

If you have been scrolling hair-loss TikTok and seeing copper peptide scalp serums appear in every other before-and-after post, the short answer is: the mechanism has plausible biology behind it, the actual human scalp RCT evidence is thin, and the existing regulatory-approved treatments (minoxidil, finasteride) have far stronger trial backing. Copper peptides for hair are […]

Copper Peptides for Hair Loss: Legit Treatment or TikTok Hype? Read More »

Best Peptide Supplements You Can Actually Buy in 2026 (Legally, On Amazon)

If you have been searching "best peptide supplements" and wading through lists that either obsess over collagen or lean heavily toward research-chemical peptides that are not legally sold for human consumption, the short answer is: the peptide supplements worth buying on Amazon in 2026 are a handful of well-studied bioactive categories with real trial evidence,

Best Peptide Supplements You Can Actually Buy in 2026 (Legally, On Amazon) Read More »

GLP-1 Side Effect → Supplement Reference 2026

Reference page for clinicians, patients, and journalists: every common GLP-1 receptor agonist side effect, the % incidence rate from registration trials, and the evidence-anchored supplement category that addresses it. Each row links to UV’s full review for the recommended supplement. Last updated 2026-04-27. Side-effect frequencies aggregated from STEP, SURMOUNT, SCALE, and SUSTAIN trial publications. Supplement

GLP-1 Side Effect → Supplement Reference 2026 Read More »

GLP-1 Adjuncts Stack Builder

Pick your GLP-1 drug, the side effects you’re managing, and your goals. The tool returns a personalized supplement stack with evidence-anchored picks linking to our full UV reviews. This tool gives supplement-stack starting points, not medical advice. Discuss any supplement plan with your prescriber, especially if you have kidney disease, take other medications, or are

GLP-1 Adjuncts Stack Builder Read More »

Vital Proteins Collagen Peptides Review: Worth the Premium in 2026?

If you have been scrolling Amazon or Whole Foods and seeing Vital Proteins on every collagen display and wondering whether the brand premium actually delivers something the cheaper tubs do not, the short answer is: Vital Proteins is a legitimately good product, but the premium is mostly paying for brand reach, not dramatically better biochemistry.

Vital Proteins Collagen Peptides Review: Worth the Premium in 2026? Read More »

Momentous Collagen Peptides Review: The NSF-Certified Collagen Athletes Buy

If you have been comparing collagen brands and seeing Momentous keep appearing on athlete Twitter, in NSF-certification discussions, and in the Instagram feeds of professional trainers, the short answer is: Momentous is a legitimately premium product whose value depends almost entirely on whether you need NSF Certified for Sport screening. The peptide is high quality,

Momentous Collagen Peptides Review: The NSF-Certified Collagen Athletes Buy Read More »

State Medicaid GLP-1 Coverage Map 2026

Which US state Medicaid programs cover Wegovy, Zepbound, or Saxenda for adult obesity in 2026? Color-coded tile map, sortable per-state table, BMI thresholds, prior-authorization criteria, and the coverage growth trend since 2022. Updated quarterly. State Medicaid drug coverage policies change monthly. The data below is based on publicly available Medicaid Preferred Drug Lists (PDLs), KFF

State Medicaid GLP-1 Coverage Map 2026 Read More »

FDA GLP-1 Compounding Enforcement Timeline (2022-2026)

Chronological reference of FDA actions and major court rulings affecting compounded semaglutide and tirzepatide from the start of the GLP-1 shortages (2022) through April 2026. Each event has its own permalink anchor and is sourced to FDA documents, court filings, or contemporaneous coverage. Last updated: 2026-04-27. The compounded-GLP-1 enforcement story is still unfolding — we

FDA GLP-1 Compounding Enforcement Timeline (2022-2026) Read More »

GLP-1 Statistics & Market Data 2026: 75+ Citable Numbers

Citable numbers on GLP-1 receptor agonists (semaglutide, tirzepatide, liraglutide, dulaglutide, exenatide) — market size, prescription volume, user demographics, clinical outcomes, pricing, insurance, side effects, and regulatory actions. Every stat is sourced. Use the anchor links to cite specific numbers. Last updated: 2026-04-27. Statistics on this page are gathered from FDA prescribing information, peer-reviewed clinical trials

GLP-1 Statistics & Market Data 2026: 75+ Citable Numbers Read More »

Which Peptide for Me? Decision Tree

A guided 5-question wizard that maps you to the FDA-approved peptide options most likely to match your situation. Restricted to FDA-approved peptides — every answer ends with “consult your prescriber.” This is not medical advice and does not replace a clinician. The recommendations are conversation starters for your prescriber, not prescriptions. Final decisions belong to

Which Peptide for Me? Decision Tree Read More »

Scroll to Top